Your Dedicated Platform for Structure-Based Drug Design to Foster New & Existing Relationships with Key Decision Makers Seeking Your Expertise
The 2nd Structure-Based Drug Design Summit San Diego is designed to address the most critical challenges in translating high-resolution structural insight into higher-quality, developable drug candidates.
Developed in close collaboration with structural biology pioneers across pharma, biotech, and academia, the summit focuses on advancing progress across key areas, including:
- Integrating AI-enabled structure prediction and de novo design with experimental validation to improve confidence in target assessment and molecule design
- Solving structures for complex targets and emerging modalities, including conformational dynamics, cryptic pockets, and challenging membrane and multi-protein systems
- Scaling cryo-EM throughput through automation, addressing access, sample preparation, and data processing bottlenecks
- Extending SBDD beyond conventional small molecules to protein degraders, biologics, and next-generation therapeutic modalities
- Construct design, protein expression, and stabilization strategies to address critical experimental bottlenecks
- Translating structural insights into broader molecular optimization, connecting structure-guided design with candidate progression to deliver better molecules more efficiently
Partner with us in 2026 to position your organization as a leader in structure-based drug design innovation and gain direct access to a highly targeted audience of senior structural biology, computational chemistry, and drug discovery leaders actively seeking new technologies, platforms, services, and strategic partnerships.
What to Expect?
The 2nd Structure-Based Drug Design Summit San Diego offers a unique opportunity to raise your brand visibility among the scientific decision-makers advancing the next generation of structure-enabled drug discovery. Position yourself directly in front of structural biologists, computational chemists, medicinal chemists, and biotech leaders actively seeking partners to overcome challenges across:
- AI-enabled structure prediction and de novo design, including benchmarking, validation, and integration with experimental structural biology
- Solving structures for complex targets and emerging modalities, including membrane proteins, GPCRs, and multi-protein complexes
- Cryo-EM throughput and automation, including sample preparation, data processing, and scalable structural workflows
- Extending structure-based drug design beyond small molecules, including protein degraders, biologics, and complex therapeutic modalities
- Construct design, protein expression, and structure determination to overcome critical experimental bottlenecks
- Translating structural insight into candidate progression, including hit prioritization, lead optimization, and developability
This summit is deliberately curated to enable high-value scientific and commercial partnerships, creating an intimate, highly technical environment where solution providers can engage directly with senior structural biology, computational chemistry, and drug discovery leaders evaluating new technologies, platforms, and strategic collaborations to accelerate structure-based drug discovery.
Powering Innovation in Structure-Based Drug Design Research
Attendees from leading biopharma and biotech companies are actively seeking partners with expertise in structural biology, computational modelling, protein production, and structure-guided drug design. Partnering with the 2nd Structure-Based Drug Design Summit San Diego connects you directly with the decision-makers developing the next generation of structure-enabled drug discovery pipelines.
This is where solution providers meet the leaders shaping safer, more effective, and higher-quality drug candidates from target characterization through candidate optimization.
Structural Drug Discovery CROs (Cryo-EM, NMR, Crystallography)
Structural biology teams require specialist partners to generate high-resolution structural insight into challenging and complex targets. Showcase your expertise in cryo-EM, NMR, X-ray crystallography, and integrative structural biology to help drug discovery teams break down data silos, resolve conformational dynamics, and accelerate structure-guided decision making.
Discovery CROs
Structure-based drug design developers require integrated partners to accelerate programs from target identification through hit-to-lead optimization. Demonstrate your expertise in full-spectrum drug discovery services, spanning biology, medicinal chemistry, and preclinical development, to help teams streamline discovery, reduce risk, and progress structurally-enabled candidates faster.
Antibody Engineers
As developers seek to expand structure-guided design into biologics and next-generation modalities, specialized antibody engineering platforms are critical for identifying differentiated binders and optimized formats. Demonstrate how your platform enables rapid design, optimization, and structural characterization of antibodies, bispecifics, and complex biologic architectures.
Protein Providers/ Samples
Structural biology techniques like X-ray crystallography and cryo-EM require high-quality, pure protein samples to determine 3D structure and generate meaningful biological insight. Position your portfolio as an essential resource for accelerating structure-based drug design and structural characterization workflows.
Data Storage
Structural biology techniques generate vast, complex datasets that need to be efficiently stored, processed, and shared to support high-throughput decision making. Demonstrate how your cloud-based or infrastructure solutions enable structural biology teams to move from data to discovery faster.
Equipment Providers
High-resolution structural biology relies on specialized, high-value instrumentation, from cryo-electron microscopes to X-ray crystallography systems. Showcase how your equipment and instrumentation empower biopharma and academic teams to generate the high-quality structures needed to drive drug discovery decisions.
Computational Platforms & Software
As AI and de novo design tools reshape structure-based drug design, computational platforms are becoming a critical starting point for structure prediction, binding pose analysis, and molecule design. Highlight how your software enables researchers to identify novel drug targets, design more effective candidates, and integrate predictive modelling with experimental validation.
Hear What Our Past Sponsors Have to Say
The audience was just right for us. We are a vendor and solution provider in the space so having lots of cryo-EM and SBDD people there was great.
Structura Biotechnology
The caliber of the attendees was very high, and the meeting content was excellent
Evotec
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as badges, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Dylan Paul
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company’s goals.